Researchers detected tiny tumor DNA fragments in blood, potentially enabling more sensitive cancer screening methods in the future.

Researchers detected tiny tumor DNA fragments in blood, enabling more sensitive cancer screening. The breakthrough was shared on September 5, 2025. This could lead to earlier diagnoses.